Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan Curatis Holding AG and Neupharma Co., Ltd. a…
Fierce Healthcare Names SpotitEarly a “Fierce 15” Company of 2026 SpotitEarly, a multi-cancer early detection startup that uses AI and trained canines to identify cancer odor signatures in breath samples,…
NRC Health Announces $60 Million Share Repurchase Authorization National Research Corporation, doing business as NRC Health, has announced that its Board of Directors has approved a new stock repurchase program…
MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era MindWalk Holdings Corp. a bio-native AI company, today announced B Cell Llama™, a platform…
Savara Provides Regulatory Update on MOLBREEVI Development Program for Autoimmune Pulmonary Alveolar Proteinosis Savara clinical-stage biopharmaceutical company focused on developing treatments for rare respiratory diseases, has announced a significant regulatory…
DiaMedica Therapeutics Receives Health Canada Clearance to Initiate Phase 2 Study of DM199 in Preeclampsia DiaMedica Therapeutics Inc. a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal…
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM) Affinia Therapeutics an innovative gene therapy company with a pipeline…
Pulse Biosciences’ nPulse™ Vybrance™ System to be Featured in Multiple Presentations at the North American Society for Interventional Thyroidology Meeting Pulse Biosciences, Inc. developer of the novel nPulse™ technology using…
Humana Introduces New Value-Based Cardiology Care Partnerships for Medicare Advantage Members Humana Inc. a leading U.S. healthcare company, today announced new partnerships to improve heart health for eligible Medicare Advantage members…
Prothena’s Strategic Move to Boost Shareholder Confidence and Financial Flexibility Why are biotechnology companies increasingly turning to share repurchase plans to optimize their financial strategies? Prothena Corporation plc, a late-stage…
Sarepta Supports Educational Ambitions of Duchenne Community with $5,000 Scholarships Why is supporting the education of individuals with Duchenne muscular dystrophy crucial for the future of rare disease treatment? Sarepta…
Qure.ai’s Latest FDA Clearance Enhances Early Detection and Clinical Support in Chest Radiography Why is the early detection of abnormalities in chest X-rays critical for patient outcomes? Qure.ai, a global…